Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection

Journal of Virology

Volumn 83, Issue 7, 2009, Pages 3258-3267

  Shen, Ruizhong ^a   Richter, Holly E ^b   Clements, Ronald H ^a   Novak, Lea ^c   Huff, Kayci ^a   Bimczok, Diane ^a   Sankaran Walters, Sumathi ^d   Dandekar, Satya ^d   Clapham, Paul R ^e   Smythies, Lesley E ^a   Smith, Phillip D ^a,b,f  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; GREEN FLUORESCENT PROTEIN; LEUKOCYTE ANTIGEN; VIRUS RECEPTOR;

ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CONFOCAL MICROSCOPY; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; INOCULATION; INTESTINE MUCOSA; LAMINA PROPRIA; MACROPHAGE; MOLECULAR CLONING; MONOCYTE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RNA ANALYSIS; VAGINA MUCOSA; VIRUS ENTRY; VIRUS REPLICATION; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; ORGAN CULTURE TECHNIQUE; VAGINA; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, CD; FEMALE; HIV-1; HUMANS; INTESTINAL MUCOSA; MACROPHAGES; ORGAN CULTURE TECHNIQUES; RECEPTORS, HIV; VAGINA;

EID: 63149107945     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01796-08     Document Type: Article

References (62)

1. Alexander, N. J. 1990. Sexual transmission of human immunodeficiency virus: virus entry into the male and female genital tract. Fertil. Steril. 54:1-18.
2. Boyaka, P. N, J. R. McGhee, C. Czerkinsky, and J. Mestecky. 2005. Mucosal vaccines: an overview, p. 855-873. In J. Mestecky, J. Bienenstock, M. E. Lamm, L. Mayer, J. R. McGhee, and W. Strober (ed.), Mucosal Immunology, 3rd ed. Elsevier/Academic Press, Amsterdam, The Netherlands.
3. + T-cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200:749-759.
4. Collins, K. B., B. K. Patterson, G. J. Naus, D. V. Landers, and P. Gupta. 2000. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat. Med. 6:475-479.
5. Crowe, S., T. Zhu, and W. A. Muller. 2003. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J. Leukoc. Biol. 74:635-641.
6. Derdeyn, C. A., J. M. Decker, J. N. Sfakianos, X. Wu, W. A. O'Brien, L. Ratner, J. C. Kappes, G. M. Shaw, and E. Hunter. 2000. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gpl20. J. Virol. 74:8358-8367.
7. Forthal, D. N., G. Landucci, J. Bream, L. P. Jacobson, T. B. Phan, and B. Montoya. 2007. FcγRIIa genotype predicts progression of HIV infection. J. Immunol. 179:7916-7923.
8. Fraziano, M., G. Cappelli, M. Santucci, F. Mariani, M. Amicosante, M. Casarini, S. Giosue, A, Bisetti, and V. Colizzi. 1999. Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macro-phages in the course of in vivo and in vitro Mycobacterium tuberculosis infection. AIDS Res. Hum. Retrovir. 15:869-874.
9. Greenhead, P., P. Hayes, P. S. Watts, K. G. Laing, G. E. Griffin, and R. J. Shattock. 2000. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 74:5577-5586.
10. + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77:11708-11717.
11. Guadalupe, M., S. Sankaran, M. D. George, E. Reay, D. Verhoeven, B. L. Shacklett, J. Flamm, J. Wegelin, T. Prindiville, and S. Dandekar. 2006. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J. Virol. 80:8236-8247.
12. + T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-l)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 76:9868-9876.
13. Hladik, F., P. Sakchalathorn, L. Ballweber, G. Lentz, M. Fialkow, D. Eschenbach, and M. J. McElrath. 2007. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26:257-270.
14. Kedzierska, K., S. M. Crowe, S. Turville, and A. L. Cunningham. 2003. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev. Med. Virol. 13:39-56.
15. Kutsch, O., E. N. Benveniste, G. M. Shaw, and D. N. Levy. 2002. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J. Virol. 76:8776-8786.
16. Lee, S. H., P. M. Starkey, and S. Gordon. 1985. Quantitative analysis of total macrophage content in adult mouse tissues: immunochemical studies with monoclonal antibody F4/80. J. Exp. Med. 161:475-489.
17. Li, L., G. Meng, M. F. Graham, G. M. Shaw, and P. D. Smith. 1999. Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5. Gastroenterology 116:1043-1053.
18. + T cells. Nature 434:1148-1152.
19. Li, Y., J. C. Kappes, J. A. Conway, R. W. Price, G. M. Shaw, and B. H. Hahn. 1991. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J. Virol. 65:3973-3985.
20. Maheshwari, A., L. E. Smythies, X. Wu, L. Novak, R. Clements, D. Eckhoff, A. J. Lazenby, W. J. Britt, and P. D. Smith. 2006. Cytomegaloviras blocks intestinal stroma-induced down-regulation of macrophage HIV-1 infection. J. Leukoc. Biol. 80:1111-1117.
21. + T cells in multiple tissues during acute SIV infection. Nature 434:1093-1097.
22. + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200:761-770.
23. + T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J. Virol. 81:599-612.
24. Meng, G., M. Sellers, M. Mosteller-Barnum, T. Rogers, G. Shaw, and P. Smith. 2000. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa. J. Infect. Dis. 182:785-791.
25. + cells. Nat. Med. 8:150-156.
26. Mestecky, J. 2006. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites. J. Reprod. Immunol. 72:1-17.
27. Mestecky, J., Z. Moldoveanu, and M. W. Russell. 2005. Immunologic uniqueness of the genital tract: challenge for vaccine development. Am. J. Reprod. Immunol. 53:208-214.
28. Moldoveanu, Z., W. Q. Huang, R. Kulhavy, M. S. Pate, and J. Mestecky. 2005. Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity. J. Immunol. 175: 4127-4136.
29. Montaner, L. J., S. M. Crowe, S. Aquaro, C. F. Perno, M. Stevenson, and R. G. Collman. 2006. Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. J. Leukoc. Biol. 80:961-964.
30. Moroney, S. M., L. C. Heller, and R. H. Widen. 2006. Evaluation of two TaqMan PCR assays for the detection of HIV-1 proviral DNA in blood samples. J. Microbiol. Methods 65:350-353.
31. Newman, G. W., G. H. Kelley, H. Gan, O. Kandil, M. J. Newman, P. Pink-ston, R. M. Rose, and H. G. Remold. 1993. Concurrent infection of human macrophages with HIV-1 and Mycobacterium avium results in decreased cell viability, increased M. avium multiplication and altered cytokine production. J. Immunol. 151:2261-2272.
32. Orenstein, J. M., C. Fox, and S. M. Wahl. 1997. Macrophages as a source of HIV during opportunistic infections. Science 276:1857-1861.
33. Peters, P. J., J. Bhattacharya, S. Hibbitts, M. T. Dittmar, G. Simmons, J. Bell, P. Simmonds, and P. R. Clapham. 2004. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J. Virol. 78:6915-6926.
34. Peterson, P. K., G. Gekker, C. C. Chao, S. Hu, C. Edelman, H. H. Balfour, and J. Verhoef. 1992. Human cytomegaloviras-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-α-mediated mechanism. J. Clin. Investig. 89:574-580.
35. Pudney, J., A. J. Quayle, and D. J. Anderson. 2005. Immunological micro-environments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 73:1253-1263.
36. Royce, R. A., A. Sena, W. Cates, Jr., and M. S. Cohen. 1997. Sexual transmission of HIV. N. Engl. J. Med. 336:1072-1078.
37. Rugtveit, J., A. Bakka, and P. Brandtzaeg. 1997. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin. Exp. Immunol. 110:104-113.
38. Russell, M. W., and J. Mestecky. 2002. Humoral immune responses to microbial infections in the genital tract. Microbes Infect. 4:667-677.
39. Schenk, M., A. Bouchon, S. Tirrer, M. Colonna, and C. Mueller. 2005. Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine. J. Immunol. 174:517-524.
40. Schenk, M., A. Bouchon, F. Seibold, and C. Mueller. 2007. TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J. Clin. Investig. 117:3097-3106.
41. Sharova, N., C. Swingler, M. Sharkey, and M. Stevenson. 2005. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J. 24:2481-2489.
42. Shattock, R. J., and J. P. Moore. 2003. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 1:25-34.
43. Sheffield, J. S., G. D. Wendel, Jr., D. D. Mclntire, and M. V. Norgard. 2007. Effect of genital ulcer disease on HIV-1 coreceptor expression in the female genital tract. J. Infect. Dis. 196:1509-1516.
44. + T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J. Virol. 72:6646-6656.
45. Smith, P. D., E. N. Janoff, M. Mosteller-Barnum, M. Merger, J. M. Orenstein, J. F. Kearney, and M. F. Graham. 1997. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine. J. Immunol. Methods 202:1-11.
46. Smith, P. D., C. Ochsenbauer-Jambor, and L. E. Smythies. 2005. Intestinal macrophages: unique effector cells of the innate immune system. Immunol. Rev. 206:149-159.
47. Smith, P. D., S. S. Saini, M. Raffeld, J. F. Manischewitz, and S. M. Wahl. 1992. Cytomegalovirus induction of tumor necrosis factor-α by human monocytes and mucosal macrophages. J. Clin. Investig. 90:1642-1648.
48. Smith, P. D., L. E. Smythies, M. Mosteller-Barnum, D. A. Sibley, M. W. Russell, M. Merger, M. F. Graham, T. Shimada, and H. Kubagawa. 2001. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 167:2651-2656.
49. Smith, P. D., L. E. Smythies, and S. M. Wahl. 2001. Macrophage effector function, p. 19.1-19.9. In R. R. Rich, T. A. Fleisher, W. T. Sherarer, B. Kotzin, and H. W. J. Schroeder (ed.), Clinical immunology, 2nd ed., vol. 1. Harcourt Health Sciences, London, England.
50. Smythies, L. E., A. Maheshwari, R. H. Clements, D. Eckhoff, L. Novak, M. Mosteller-Barnum, M. Sellers, and P. D. Smith. 2006. Mucosal IL-8 and TGF-β recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells. J. Leukoc. Biol. 80:492-499.
51. Smythies, L. E., M. Sellers, R. H. Clements, M. Mosteller-Barnum, G. Meng, W. H. Benjamin, J. M. Orenstein, and P. D. Smith. 2005. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bactericidal activity. J. Clin. Investig. 115:66-75.
52. Smythies, L. E., L. M. Wahl, and P. D. Smith. 2006. Isolation and purification of human intestinal macrophages, p. 7.6B.1-7.6B.19. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York, NY.
53. + T-cell depletion and viral replication in SIV infection. Science 280:427-431.
54. Veazey, R. S., P. J. Klasse, T. J. Ketas, J. D. Reeves, M. Piatak, Jr., K. Kunstman, S. E. Kuhmann, P. A. Marx, J. D. Lifson, J. Dufour, M. Mefford, I. Pandrea, S. M. Wolinsky, R. W. Doms, J. A. DeMartino, S. J. Siciliano, K. Lyons, M. S. Springer, and J. P. Moore. 2003. Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. J. Exp. Med. 198: 1551-1562.
55. Veazey, R. S., P. J. Klasse, S. M. Schader, Q. Hu, T. J. Ketas, M. Lu, P. A. Marx, J. Dufour, R. J. Colonno, R. J. Shattock, M. S. Springer, and J. P. Moore. 2005. Protection of macaques from vaginal SHIV challenge by vag-inally delivered inhibitors of virus-cell fusion. Nature 438:99-102.
56. + T cells express high levels of CCR5 and are rapidly depleted in simian immunodeficiency virus infection. J. Infect. Dis. 187:769-776.
57. Veazey, R. S., M. S. Springer, P. A. Marx, J. Dufour, P. J. Klasse, and J. P. Moore. 2005. Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor. Nat. Med. 11:1293-1294.
58. + T cells in gut mucosa but enhances their rapid restoration through central memory T cells. J. Virol. 82:4016-4027.
59. Wahl, L., S. M. Wahl, L. E. Smythies, and P. D. Smith. 2006. Isolation of human monocyte populations, p. 7.6A.1-7.6A.10. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York, NY.
60. Wahl, S. M., T. Greenwell-Wild, G. Peng, H. Hale-Donze, T. M. Doherty, D. Mizel, and J. M. Orenstein. 1998. Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression. Proc. Natl. Acad. Sci. USA 95:12574-12579.
61. Wu, X., J. K. Wakefield, L. Hongmei, H. Xiao, R. Kralovics, J. T. Prchal, and J. C. Kappes. 2000. Development of a novel trans-lentiviral vector that afford predictable safety. Mol. Ther. 2:47-55.
62. + T cells. Science 286:1353-1357.